المؤلفون: Jonathan W. Goldman, Julien Mazieres, Fabrice Barlesi, Konstantin H. Dragnev, Marianna Koczywas, Tuncay Göskel, Alexis B. Cortot, Nicolas Girard, Claas Wesseler, Helge Bischoff, Ernest Nadal, Keunchil Park, Shun Lu, Alvaro Taus, Manuel Cobo, Shawn T. Estrem, Sameera R. Wijayawardana, Kellie Turner, Gerard Joseph Oakley, Karla C. Hurt, Alan Y. Chiang, Anwar M. Hossain, William J. John, Luis Paz-Ares

المصدر: Frontiers in Oncology, Vol 10 (2020)

مصطلحات موضوعية: platinum-resistant, erloitinib, abemaciclib, KRAS, NSCLC, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2020.578756/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/4c938db73a4443b18e2317f0a0f304fdTest

المؤلفون: Tuncay Göskel, Alan Y. Chiang, Fabrice Barlesi, Shun Lu, Gerard J. Oakley, Alexis B. Cortot, Helge Bischoff, Álvaro Taus, Keunchil Park, Jonathan W. Goldman, Nicolas Girard, C. Wesseler, Sameera R. Wijayawardana, Kellie Turner, Shawn T. Estrem, Ernest Nadal, Karla Hurt, Luis Paz-Ares, William J. John, Konstantin H. Dragnev, Manuel Cobo, Julien Mazieres, Marianna Koczywas, Anwar Hossain

المساهمون: Ege Üniversitesi

المصدر: Frontiers in Oncology, Vol 10 (2020)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, abemaciclib, medicine.disease_cause, NSCLC, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, KRAS, neoplasms, erloitinib, Chemotherapy, business.industry, Hazard ratio, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Confidence interval, respiratory tract diseases, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Toxicity, Erlotinib, business, platinum-resistant, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8102b42793bed505aef10f7c7c22be12Test
https://hdl.handle.net/11454/61824Test

المؤلفون: Jonathan W. Goldman, Julien Mazieres, Fabrice Barlesi, Konstantin H. Dragnev, Marianna Koczywas, Tuncay Göskel, Alexis B. Cortot, Nicolas Girard, Claas Wesseler, Helge Bischoff, Ernest Nadal, Keunchil Park, Shun Lu, Alvaro Taus, Manuel Cobo, Shawn T. Estrem, Sameera R. Wijayawardana, Kellie Turner, Gerard Joseph Oakley, Karla C. Hurt, Alan Y. Chiang, Anwar M. Hossain, William J. John, Luis Paz-Ares

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, platinum-resistant, erloitinib, abemaciclib, KRAS, NSCLC

العلاقة: https://figshare.com/articles/dataset/DataSheet_1_A_Randomized_Phase_III_Study_of_Abemaciclib_Versus_Erlotinib_in_Patients_with_Stage_IV_Non-small_Cell_Lung_Cancer_With_a_Detectable_KRAS_Mutation_Who_Failed_Prior_Platinum-Based_Therapy_JUNIPER_docx/13141247Test

الإتاحة: https://doi.org/10.3389/fonc.2020.578756.s001Test
https://figshare.com/articles/dataset/DataSheet_1_A_Randomized_Phase_III_Study_of_Abemaciclib_Versus_Erlotinib_in_Patients_with_Stage_IV_Non-small_Cell_Lung_Cancer_With_a_Detectable_KRAS_Mutation_Who_Failed_Prior_Platinum-Based_Therapy_JUNIPER_docx/13141247Test